Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon G Adler

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Endocrinology|March 28, 2009
Heat shock protein 27 overexpression mitigates cytokine-induced islet apoptosis and streptozotocin-induced diabetesTiane Dai, Mina Patel-Chamberlin, Rama Natarajan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2005
P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studiesZhong-Gao Xu, Dong-Ryeol Ryu, Tae-Hyun Yoo, et al.
American Journal of Human Genetics|June 15, 2007
A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mappingChao Tian, David A Hinds, Russell Shigeta, et al.
American Journal of Nephrology|December 20, 2003
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathyW Kline Bolton, Daniel C Cattran, Mark E Williams, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Kidney International|March 11, 2011
Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across speciesMina Patel-Chamberlin, Ying Wang, Bancha Satirapoj, et al.
Diabetes|March 22, 2014
Time to look back and to look forwardK Sreekumaran Nair, E Dale Abel, Sharon G Adler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2014
Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencingAnuja Shah, Clinton J Miller, Cynthia C Nast, et al.
Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.
Glomerular Diseases|February 8, 2023
Association between Psychiatric Disorders and Glomerular DiseaseHailey E Desmond, Clare Lindner, Jonathan P Troost, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Endocrinology|March 28, 2009
Heat shock protein 27 overexpression mitigates cytokine-induced islet apoptosis and streptozotocin-induced diabetesTiane Dai, Mina Patel-Chamberlin, Rama Natarajan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2005
P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studiesZhong-Gao Xu, Dong-Ryeol Ryu, Tae-Hyun Yoo, et al.
American Journal of Human Genetics|June 15, 2007
A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mappingChao Tian, David A Hinds, Russell Shigeta, et al.
American Journal of Nephrology|December 20, 2003
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathyW Kline Bolton, Daniel C Cattran, Mark E Williams, et al.
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Kidney International|March 11, 2011
Hematopoietic growth factor inducible neurokinin-1 (Gpnmb/Osteoactivin) is a biomarker of progressive renal injury across speciesMina Patel-Chamberlin, Ying Wang, Bancha Satirapoj, et al.
Diabetes|March 22, 2014
Time to look back and to look forwardK Sreekumaran Nair, E Dale Abel, Sharon G Adler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2014
Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencingAnuja Shah, Clinton J Miller, Cynthia C Nast, et al.
Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.
Glomerular Diseases|February 8, 2023
Association between Psychiatric Disorders and Glomerular DiseaseHailey E Desmond, Clare Lindner, Jonathan P Troost, et al.
Pageof 8